Wednesday, July 16, 2008 10:57:11 AM
Parasite immunity: Why worms are a turn off
Nature Reviews Immunology
http://www.signaling-gateway.org/update/updates/200301/nri989.html
Chistosome lyso-phosphatidylserine seems to signal through TLR2 to direct the induction of IL-10-secreting helper T cells, possibly accounting for the skewing to IL-10 production and T-cell hyporesposiveness that is seen during chronic schistosomiasis.
Researchers at Leiden University have identified a schistosome lipid that seems to interact with the innate immune system through a Toll-like receptor (TLR). Interestingly, rather than promoting T-cell activation, this interaction induces the development of T cells with immunosuppressive potential.
Schistosomes are parasitic worms that chronically infect more than 200 million people in developing countries. Owing to complex interactions between the host immune system and the parasite — the product of a long period of co-evolution — the schistosomes can survive for many years.
In recent years, lipids have emerged as important modulators of the innate immune system. So, van der Kleij and colleagues set out to investigate the effects of schistosome lipids on the host immune response. Lipids from Schistosoma mansoni were fractionated using an ion-exchange column and then tested for their capacity to induce cytokine production.
A fraction containing phosphatidylserine was found to affect the maturation of dendritic cells (DCs) such that they induced the development of T cells secreting the immunosuppressive cytokine interleukin-10 (IL-10) in vitro. In co-culture, these T cells suppressed the proliferation of autologous T cells, an effect that was blocked by IL-10-specific antibodies. This effect seems to be specific for phosphatidylserine, as other schistosome extracts failed to induce the production of IL-10 by T cells in vitro. Mammalian phosphatidylserine had no effect on DC maturation.
Members of the TLR family have been shown to recognize other pathogen-associated lipids, and so they were candidates receptors for interaction with the schistosome phosphatidyl fraction. Antibodies specific for TLR2 blocked the induction of IL-10-secreting T cells by phosphatidylserine in vitro, indicating that TLR2 might be involved in the recognition of schistosome phosphatidylserine. Phospholipase digestion of the phosphatidylserine lipid fraction reduced its TLR2-stimulating capacity, confirming that the active moiety is a phosphatidylserine and not a contaminant. Further fractionation of the worm phosphatidylserine by HPLC pinpointed the TLR2-activating and IL-10-promoting activity to a lyso-phosphatidylserine fraction.
So, schistosome lyso-phosphatidylserine seems to signal through TLR2 to direct the induction of IL-10-secreting helper T cells, which might account for the skewing to IL-10 production and T-cell hyporesposiveness that is seen during chronic schistosomiasis.
-----------------------
j
Recent CDMO News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/07/2024 02:59:47 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/07/2024 02:42:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 02:11:21 AM
- Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction • GlobeNewswire Inc. • 11/06/2024 11:04:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 08:45:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2024 11:40:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:37:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:22:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:21:22 AM
- Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference • GlobeNewswire Inc. • 09/12/2024 08:05:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/09/2024 08:43:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:19:30 PM
- Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 • GlobeNewswire Inc. • 09/09/2024 08:05:31 PM
- U.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply Concerns • IH Market News • 09/09/2024 10:09:14 AM
- Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 • GlobeNewswire Inc. • 09/03/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 08:30:10 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/28/2024 08:34:04 PM
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • Nov 7, 2024 8:48 AM
FEATURED SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • Nov 7, 2024 7:00 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM